Clémence Boutière

692 total citations
25 papers, 348 citations indexed

About

Clémence Boutière is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Clémence Boutière has authored 25 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 10 papers in Neurology and 9 papers in Immunology. Recurrent topics in Clémence Boutière's work include Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (7 papers) and Polyomavirus and related diseases (7 papers). Clémence Boutière is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (7 papers) and Polyomavirus and related diseases (7 papers). Clémence Boutière collaborates with scholars based in France, Italy and Armenia. Clémence Boutière's co-authors include Audrey Rico, Jean Pelletier, Bertrand Audoin, Adil Maarouf, Romain Marignier, Corinne Brunet, Romaric Lacroix, Sylvie Cointe, Jean‐Philippe Ranjeva and Françoise Reuter and has published in prestigious journals such as Neurology, Annals of Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Clémence Boutière

24 papers receiving 345 citations

Peers

Clémence Boutière

PFM

NEURO

IMMUN

ONCOL

RHEUM

Robert A Bermel United States

Dan Whittam United Kingdom

Francisco Gascón Spain

Lynn Stazzone United States

Wiebke Stark Germany

Elisabetta Verdun di Cantogno United States

Fabio Brusaferri Italy

Svitlana Shkrobot Ukraine

Guillaume Mathey France

Carolina Rush Canada

Robert A Bermel United States

Clémence Boutière

271 ×1.1

PFM

124 ×0.7

NEURO

39 ×0.5

IMMUN

63 ×1.0

ONCOL

62 ×1.3

RHEUM

Citations per year, relative to Clémence Boutière Clémence Boutière (= 1×) peers Robert A Bermel

Countries citing papers authored by Clémence Boutière

Since Specialization

Citations

This map shows the geographic impact of Clémence Boutière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clémence Boutière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clémence Boutière more than expected).

Fields of papers citing papers by Clémence Boutière

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clémence Boutière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clémence Boutière. The network helps show where Clémence Boutière may publish in the future.

Co-authorship network of co-authors of Clémence Boutière

This figure shows the co-authorship network connecting the top 25 collaborators of Clémence Boutière. A scholar is included among the top collaborators of Clémence Boutière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clémence Boutière. Clémence Boutière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pique, Julie, et al.. (2026). Frequency of AQP4 and MOG Antibodies in Patients With Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI Criteria. Neurology. 106(7). e214753–e214753.

Stellmann, Jan‐Patrick, Clémence Boutière, Audrey Rico, et al.. (2025). Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis. Neurotherapeutics. 22(3). e00554–e00554. 2 indexed citations

Boutière, Clémence, Audrey Rico, Jan‐Patrick Stellmann, et al.. (2025). Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome. Neurology Neuroimmunology & Neuroinflammation. 12(2). e200379–e200379. 1 indexed citations

Boutière, Clémence, Audrey Rico, Jan‐Patrick Stellmann, et al.. (2025). Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis. Neurology Neuroimmunology & Neuroinflammation. 12(3). e200386–e200386. 1 indexed citations

Lépine, Anne, Adil Maarouf, Damien Biotti, et al.. (2024). Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis. Multiple Sclerosis Journal. 30(2). 261–265. 9 indexed citations

Maarouf, Adil, Audrey Rico, Clémence Boutière, et al.. (2024). Active and non-active progression independent of relapse activity within the first 20 years of relapsing multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 95(10). jnnp–2024. 1 indexed citations

Zaaraoui, Wafaa, Clémence Boutière, Audrey Rico, et al.. (2024). Cortical Lesions as an Early Hallmark of Multiple Sclerosis: Visualization by 7 T MRI. Investigative Radiology. 59(11). 747–753. 4 indexed citations

Maarouf, Adil, Clémence Boutière, Audrey Rico, et al.. (2024). Factors affecting the topography of nitrous oxide‐induced neurological complications. European Journal of Neurology. 31(7). e16291–e16291. 3 indexed citations

Boutière, Clémence, Audrey Rico, Frédéric Vely, et al.. (2024). Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200231–e200231. 2 indexed citations

10.

Joubert, Bastien, Marie Bénaiteau, Clémence Boutière, et al.. (2024). Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis. Neurology. 102(8). e209284–e209284. 1 indexed citations

11.

Maarouf, Adil, et al.. (2023). Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception. Neurology Neuroimmunology & Neuroinflammation. 10(5). 5 indexed citations

12.

Rico, Audrey, Clémence Boutière, Frédéric Vely, et al.. (2023). Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 22 indexed citations

13.

Maarouf, Adil, Bertrand Audoin, Mohamed Mounir El Mendili, et al.. (2022). Grey-matter sodium concentration as an individual marker of multiple sclerosis severity. Multiple Sclerosis Journal. 28(12). 1903–1912. 3 indexed citations

14.

Pique, Julie, Adil Maarouf, Clémence Boutière, et al.. (2022). Pure Relapsing Short Myelitis. Neurology Neuroimmunology & Neuroinflammation. 9(4). 5 indexed citations

15.

Rico, Audrey, Läétitia Ninove, Adil Maarouf, et al.. (2021). Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(4). 3080425342–3080425342. 5 indexed citations

16.

Rico, Audrey, Clémence Boutière, Adil Maarouf, et al.. (2019). Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin‐4 Antibody Diseases. Annals of Neurology. 87(2). 256–266. 108 indexed citations

17.

Maarouf, Adil, Clémence Boutière, Audrey Rico, Bertrand Audoin, & Jean Pelletier. (2018). How much progress has there been in the second-line treatment of multiple sclerosis: A 2017 update. Revue Neurologique. 174(6). 429–440. 6 indexed citations

18.

Rico, Audrey, J. Séguier, Clémence Boutière, et al.. (2018). Life-threatening autoimmune warm hemolytic anemia following treatment for multiple sclerosis with alemtuzumab. Multiple Sclerosis Journal. 24(6). 811–813. 14 indexed citations

19.

Ayrignac, Xavier, Clémence Boutière, Clarisse Carra‐Dallière, & Pierre Labauge. (2016). Posterior fossa involvement in the diagnosis of adult-onset inherited leukoencephalopathies. Journal of Neurology. 263(12). 2361–2368. 4 indexed citations

20.

Fourneret, Pierre, et al.. (2004). Approche diagnostique et thérapeutique actuelle des troubles obsessionnels compulsifs chez l’enfant. Archives de Pédiatrie. 11(3). 285–294. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact